The heterogeneity of metabolic syndrome presentation and challenges this causes in its pharmacological management: a narrative review focusing on principal risk …

A Lonardo - Expert Review of Clinical Pharmacology, 2023 - Taylor & Francis
ABSTRACT Introduction Metabolic syndrome (MetS), ie the cluster of cardiometabolic risk
factors comprising visceral obesity, impaired glucose metabolism, arterial hypertension and …

[HTML][HTML] Special Aspects of Cholesterol Metabolism in Women

I Gouni-Berthold, U Laufs - Deutsches Ärzteblatt International, 2024 - pmc.ncbi.nlm.nih.gov
Background Cardiovascular diseases due to arteriosclerosis are the most common causes
of death and disability in both men and women. Hypercholesterolemia, a treatable risk …

[HTML][HTML] Lipoprotein Metabolism, Dyslipidemia, and Lipid-Lowering Therapy in Women: A Comprehensive Review

JM Zimodro, M Mucha, HK Berthold, I Gouni-Berthold - Pharmaceuticals, 2024 - mdpi.com
Lipid-lowering therapy (LLT) is a cornerstone of atherosclerotic cardiovascular disease
prevention. Although LLT might lead to different reductions in low-density lipoprotein …

Sex differences in the intensity of statin prescriptions at initiation in a primary care setting

PAJ Kiss, A Uijl, AR de Boer, TCX Duk, DE Grobbee… - Heart, 2024 - heart.bmj.com
Background Current guidelines for the prevention and management of cardiovascular
diseases (CVD) provide similar recommendations for the use of statins in both women and …

[HTML][HTML] Unique cardiometabolic factors in women that contribute to modified cardiovascular disease risk

K Hetherington, J Thomas, SJ Nicholls… - European Journal of …, 2024 - Elsevier
Major risk factors of cardiovascular disease (CVD) include hypertension, obesity, diabetes
mellitus and metabolic syndrome; all of which are considered inflammatory conditions …

Bridging the gap: understanding sex differences in low-density lipoprotein cholesterol control through the lens of integrated data analysis and behavioural sciences

MJ Machline-Carrion - Heart, 2024 - heart.bmj.com
Low-density lipoprotein cholesterol (LDL-C) is a well-known risk factor for cardiovascular
disease, a leading cause of morbidity and mortality worldwide. Traditionally, guidelines for …

Sex aspects in lipoprotein metabolism, dyslipidemia, and lipid-lowering therapy: A comprehensive review

JM Zimodro, M Mucha, HK Berthold, I Gouni-Berthold - 2024 - preprints.org
Lipid-lowering therapy (LLT) is a cornerstone of atherosclerotic cardiovascular disease
prevention. Although LLT might lead to different reductions in low-density lipoprotein …

Gender-Specific Lifestyle Risk Behaviors and Machine Learning Models for Predicting Atherosclerotic Cardiovascular Disease

HJ Kim, H Choi, HJ Ahn, SH Shin, C Kim, SH Lee… - 2024 - researchsquare.com
Atherosclerotic cardiovascular disease (ASCVD) is a leading cause of global morbidity and
mortality. We aimed to assess the predictive accuracy of machine learning (ML) models …

Visual Viper: a portable visualization library for streamlined scientific communications.

MBNC Pais - 2023 - repositorio-aberto.up.pt
As the healthcare sector undergoes digital transformation, the influx of data for health
professionals and researchers has surged. The increased need for data visualizations to …

Visual Viper: A Portable Visualization Library for Streamlined Scientific Communications

M Canelas-Pais - 2023 - search.proquest.com
Background: The healthcare industry is seeing a digital revolution, resulting in an ever-
growing influx of data. This transformation creates an urgent need for efficient and …